HCA Healthcare (NYSE:HCA – Get Rating) had its price objective dropped by equities researchers at SVB Leerink from $304.00 to $273.00 in a note issued to investors on Monday, Benzinga reports. The brokerage presently has an “outperform” rating on the stock. SVB Leerink’s target price would indicate a potential upside of 29.61% from the stock’s […]
HCA Healthcare (NYSE:HCA – Get Rating) had its target price dropped by investment analysts at Royal Bank of Canada from $291.00 to $267.00 in a report released on Monday, Benzinga reports. The firm presently has an “outperform” rating on the stock. Royal Bank of Canada’s target price suggests a potential upside of 26.76% from the […]
HCA Healthcare (NYSE:HCA – Get Rating) had its target price reduced by Truist Financial from $310.00 to $250.00 in a report released on Monday, The Fly reports. Truist Financial’s price objective would suggest a potential upside of 16.90% from the stock’s previous close. A number of other research firms also recently weighed in on HCA. […]
HCA Healthcare (NYSE:HCA – Get Rating) had its price target decreased by equities research analysts at Wells Fargo & Company from $267.00 to $227.00 in a research note issued to investors on Monday, Benzinga reports. The brokerage currently has an “equal weight” rating on the stock. Wells Fargo & Company‘s price target suggests a potential […]
HCA Healthcare (NYSE:HCA – Get Rating) had its price objective dropped by equities researchers at Cowen from $265.00 to $241.00 in a note issued to investors on Monday, Stock Target Advisor reports. Cowen’s price objective would indicate a potential upside of 13.54% from the stock’s current price. HCA has been the subject of several other […]